Companies/JP/4544

H.U. Group Holdings,Inc. · H.U.グループホールディングス株式会社

Income flow

Annual
4544 ANNUAL Income StatementPeriod 2026-03-31Source ANNUAL
Clinical Lab Testing BusinessJPY 158BIn Vitro Diagnostics BusinessJPY 65BSterilization And Related ServicesJPY 29BRevenueJPY 247B+2% Y/YGross profitJPY 71B+6% Y/YCost of revenueJPY 176BOperating profitJPY 5B+81% Y/YOperating expensesJPY 67BNet profitJPY 7B+147% Y/YTaxJPY 2BSG&AJPY 67B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2026-03-31 · ANNUAL · JPY
By activity
By activityJPY 252.0B
  • Clinical Lab Testing BusinessJPY 157.6B62.5%
  • In Vitro Diagnostics BusinessJPY 65.0B25.8%
  • Sterilization And Related ServicesJPY 29.5B11.7%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).3.49%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.4.36%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).125PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.103.0%Shares outTotal shares currently outstanding (issued and not retired).54.3MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).54.2M
Upcoming dividend
Next ex-div
2027-03-30 · declared
Last cash
63 · 2027-03-30